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Abstract: Tuberaria lignosa (Sweet) Samp. is found in European regions, and has antioxidant properties
due to its composition in ascorbic acid and phenolic compounds. Given its traditional use and
antioxidant properties, the tumor cell growth inhibitory potential of aqueous extracts from T. lignosa
(prepared by infusion and decoction) was investigated in three human tumor cell lines: MCF-7
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and HCT-15 (human colorectal
adenocarcinoma). Both extracts inhibited the growth of these cell lines; the most potent one being
the T. lignosa extract obtained by infusion in the NCI-H460 cells (GI50 of approximately 50 µg/mL).
Further assays were carried out with this extract in NCI-H460 cells. At 100 µg/mL or 150 µg/mL
it caused an increase in the percentage of cells in the G0/G1 phase and a decrease of cells in S phase
of the cell cycle. Additionally, these concentrations caused an increase in the percentage of apoptotic
cells. In agreement, a decrease in total poly (ADP-ribose) polymerase (PARP) and pro-caspase 3 levels
was found. In conclusion, the T. lignosa extract obtained by infusion was more potent in NCI-H460
cells, altering the cell cycle progression and inducing apoptosis. This work highlights the importance
of T. lignosa as a source of bioactive compounds with tumor cell growth inhibitory potential.
Keywords: T. lignosa extracts; inhibition of tumor cell growth; H460 tumor cell line; cell cycle; apoptosis
1. Introduction
Herbal drugs have been extensively used for the treatment of several diseases all over the
world [1–3]. In particular, the interest in plants as a natural source of pharmaceutical compounds
with antitumor activity has increased in the past years. Indeed, several anti-cancer agents derived
from plants (such as vinca alkaloids, epipodophyllotoxins derivatives, taxanes, and the campothecin
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derivatives) have been discovered in the last decades [1,2,4–9]. Furthermore, several plant-derived
anticancer agents have achieved pre-clinical or clinical development [7,8,10,11].
Tuberaria lignosa (Sweet) Samp. (Rockrose like species) is a plant found in the west and south
part of Europe and is mostly present in the Iberian Peninsula, where it is known as “alcária” or
“erva loba” [12,13]. This plant has been used in traditional medicine to treat several diseases, such as
gastrointestinal disorders, viral infections, and skin infections, among others [12,13]. The preparation
of medicinal infusions and decoctions may involve the use of the whole plant or just some parts of the
plant and may be prepared fresh or shade-dried [12]. The chemical composition of T. lignosa aqueous
extracts, obtained by infusion and decoction, has been previously analyzed and compared by some of
the authors [12,13]. It has been demonstrated that infusions obtained from freeze-dried samples have
higher concentrations in compounds such as free sugars (e.g., fructose, glucose, sucrose, trehalose,
and raffinose) and lower concentrations of ascorbic acid and phenolic compounds (including ellagic
acid derivatives and flavonoids) when compared with decoctions obtained from freeze-dried samples
and infusions prepared from shade-dried samples [12]. Additionally, the freeze-dried samples also
proved to have higher antioxidant activity than the other samples and even higher than trolox, the
positive control used in the referred study [12]. Both infusion and decoction samples from T. lignosa
have bioactive molecules, such as phenolic compounds and ascorbic acid, which can explain their
antioxidant activity [12–15].
In spite of its content in such bioactive molecules, to our knowledge the tumor cell growth
inhibitory potential of this plant has never been studied. Therefore, the main objective of this work was
to investigate the tumor cell growth inhibitory effect of two aqueous extracts prepared by infusion and
decoction from Tuberaria lignosa in different human tumor cell lines: MCF-7 (breast adenocarcinoma),
NCI-H460 (non-small cell lung cancer), and HCT-15 (human colorectal adenocarcinoma). In addition,
the cellular effects of the T. lignosa extract obtained by infusion on cell cycle profile and apoptosis were
studied in more detail in the most sensitive cell line (NCI-H460).
2. Results and Discussion
2.1. T. lignosa Extracts Inhibited Tumor Cell Growth
The sulforhodamine B (SRB) assay was carried out in order to determinate the in vitro cytotoxicity
of the T. lignosa aqueous extracts, prepared by decoction and infusion, in three different human tumor
cell lines, using doxorubicin as the positive control. The results showed that T. lignosa extract obtained
by infusion was the most potent extract in the MCF-7 and in the NCI-H460 cells (Table 1). However, in
the HCT-15 cells both extracts had similar effect. Overall, the most potent extract was the infusion of
T. lignosa in the NCI-H460 cells. This is probably due to the different chemical composition of the extracts,
namely in phenolic acid derivatives, ellagic acid derivatives, and flavonoids, with infusion presenting
higher content in phenolic acid derivatives [12]. Therefore, the following analyses were conducted with
this extract (infusion). The cell line selected to continue the studies was the NCI-H460, since this was the
cell line in which the infusion extract was more potent and since it is representative of lung cancer which
has high incidence and is still one of the most common cause of cancer related deaths [16].
Table 1. GI50 concentrations of T. lignosa extracts in three human tumor cell lines.
Extracts
GI50 Concentrations (µg/mL) in Different Cell Lines
MCF-7 HCT-15 NCI-H460
Decoction 135.1 ˘ 14.6 47.0 ˘ 2.2 103.7 ˘ 19.0
Infusion 72.9 ˘ 10.2 57.5 ˘ 8.2 43.4 ˘ 7.8
GI50 concentrations correspond to the mean ˘ S.E. of at least three independent experiments, carried out
with duplicates. Doxorubicin was used as a positive control, with the following results having been obtained:
56.3 nM ˘ 14.5 in MCF-7 cells and 89.3 nM ˘ 16.7 in NCI-H460 cells. GI refers to the concentration that inhibits
50% of net cell growth. S.E. refers to standard error.
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The compounds isolated from plants with potential activity against cancer have shown multiple
mechanisms of action, such as interference with death signals thereby inducing apoptosis, disturbance
of multiple cellular signaling pathways, regulation of the cell cycle, and/or interference with cellular
invasion and metastasis [3,17–21]. For this reason, this study has further investigated the effect of the
infusion extract of T. lignosa on cell cycle and apoptosis.
2.2. T. lignosa Infusion Extract Blocked the Cell Cycle Progression of NCI-H460 Cells
To gain insight into the cytotoxic mechanism of action of the T. lignosa extract obtained by infusion,
its effect on the cell cycle was analyzed. For this, to assess a possible dose-dependent effect, NCI-H460
cells were treated with increasing concentrations of the extract: 50 µg/mL, 100 µg/mL, and 150 µg/mL
(approximately the GI50, 2 ˆ GI50, and 3 ˆ GI50 concentrations, respectively, with GI referring to the
concentration that inhibits 50% of net cell growth). Controls for the solvent of the extract (H2O) were
included. Results showed that treatment of the NCI-H460 cells with the highest tested concentrations
(100 µg/mL or 150 µg/mL) of the extract caused a statistically significant increase in the percentage
of cells in the G0/G1 phase of the cell cycle and a statistically significant decrease in the percentage
of the cells in the S phase of the cell cycle (Figure 1). In addition, for the 100 µg/mL concentration
a statistically significant decrease in the G2/M phase of the cell cycle was also observed. This data
suggested that T. lignosa infusion extract blocked the cell cycle progression of the NCI-H460 cells,
having a significant effect at 100 µg/mL and 150 µg/mL.
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Figure 1. Effect of T. lignosa infusion extract I- 460 cell cycle distribution. Cells were treated for
48 h with complete medium (Blank), with the extr µ mL, 100 µg/mL, or 150 µg/mL), or with
Contr l treatments (the two highest vehicle, H2 , c centrations). Results are the mean ˘ SEM of four
independent experiments. * p ď 0.05 and ** p ď 0.01 Blank vs. Treatment.
Various plant extracts with recognized antitumor activity have similar effects, arresting cells in
the G0/G1 phase of the cell cycle, such as ginseng extract [22], the extract of Tinospora cordifolia [23],
or the Marsdenia tenacissima extract [24].
2.3. T. lignosa Infusion Extract Induced Apoptosis in NCI-H460 Cells
The effect of T. lignosa infusion extract on cellular apoptosis was also analyzed y flow cytometry
analysis of Annexin V-FITC and propidium iodide (PI) labeling/staining. Results (Table 2) showed
an increase in the percentage of cells undergoing apoptosis after treatment with the extract, with
statistically significant results observed for the 150 µg/mL concentration treatment. Treatment of cells
with 100 µg/mL of extract also caused an increase in apoptosis to nearly twice the control levels, even
though this increase was not considered statistically significant. The reason why cellular treatment
with 100 µg/mL of extract caused statistically significant alterations in cell cycle but not in apoptosis
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is possibly because the effect on the cell cycle might precede the effect on apoptosis. Time-course
experiments would confirm this hypothesis. Nevertheless, overall this data demonstrated that this
extract caused apoptosis in NCI-H460 cells.
Table 2. Apoptosis levels in NCI-H460 cells treated with infusion extract of T. lignosa.
Conditions % Apoptosis
Blank 9.51 ˘ 0.9
Control (H2O)
Control 1 9.45 ˘ 0.3
Control 2 12.7 ˘ 1.9
T. lignosa (infusion)
50 µg/mL 15.8 ˘ 7.1
100 µg/mL 22.0 ˘ 6.1
150 µg/mL 34.7 ˘ 7.9 *
Results are the mean ˘ SEM of three independent experiments. * p ď 0.05 blank vs. treatment. Control
treatments correspond to the two highest vehicle (H2O) concentrations.
To confirm the effect on apoptosis, the effect of this extract on the expression levels of cellular
proteins involved in apoptosis was analyzed. Results from the Western blot analysis showed a decrease
in the levels of total poly (ADP-ribose) polymerase (PARP) and pro-caspase 3 (Figure 2). These results
further confirm that the T. lignosa infusion extract induced apoptosis in NCI-H460 cells. Indeed,
a reduction in the total levels of PARP is an accepted event in cellular apoptosis [25,26]. Unfortunately,
our antibody does not detect the cleaved form of caspase-3. However, the observed reduction in
pro-caspase 3 is indicative that the extract induced the intrinsic pathway of apoptosis [27,28].
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Figure 2. Effect of T. lignosa infusion extract on the NCI-H460 cellular expression levels of total PARP-1
and pro-caspase-3, analyzed by Western blot. Cells were treated for 48 h with complete medium
(Blank), Controls (vehicle of the extract, H2O), or with 50 µg/mL of the extract. β-actin was used as
loading control. Blots are representative of two independent experiments.
3. Material and Methods
3.1. Samples and Preparation of the T. lignosa Extracts
T. lignosa was collected in Miranda do Douro (Trás-os-Montes, Northeastern Portugal), as referred
in Pinela et al., 2012 [12]. The prepar ti n of decoctions and infusions followed the protocol previously
described by Pinela et al., 2012 [12]. Stock soluti of the extract were prepared in water and stored
at ´20 ˝C. Both queous extracts were previ u ly characterized by some of the authors in terms of
phenolic compo nds [12].
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3.2. Cell Culture
Three different human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460
(non-small cell lung cancer), and HCT-15 (human colorectal adenocarcinoma). All of these cells were
maintained in RPMI-1640 medium with Glutamax™, supplemented with 1 M 4-(2-Hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES) buffer and fetal bovine serum (FBS). The FBS concentration
used was 5% for the cell growth inhibition assay and 10% for the remaining assays. The monolayer
cultures were kept at 37 ˝C in a humidified incubator with 5% CO2. Cells were routinely observed
with a microscope (Nikon eclipse TS100 microscope, Nikon Instruments Europe BV, Amsterdam,
The Netherlands). All the experiments described were performed only when exponentially growing
cells presented more than 90% viability.
3.3. Cell Growth Inhibition Assay
The SRB assay was adapted from the procedure used in the NCI’s in vitro anti-cancer drug
screening [29,30]. Briefly, cells were plated in 96-well plates at their previously determined optimal
concentrations (5.0 ˆ 104 cells/mL for NCI-H460 and MCF-7 cells and 1.0 ˆ 105 cells/mL for HCT-15
cells) and incubated for 24 h. Cells were then treated with five serial dilutions of T. lignosa infusion
and T. lignosa decoction, ranging from 400 µg/mL to 25 µg/mL. Doxorubicin was used as a positive
control (ranging from 150 nM to 9.37 nM). The effect of the solvent of the extracts (water) on the
growth of the cell lines was also evaluated by treating cells with the maximum concentration of water
used. Following 48 h incubation with the extract, plates were fixed by adding ice-cold 10% ice cold
trichloroacetic acid (TCA) (w/v, final concentration, Panreac, Barcelona, Spain) and stained with
1% SRB (Sigma Aldrich, St. Louis, MO, USA) in 1% (v/v) acetic acid. Bound dye was solubilized
by adding 10 mM Tris base solution (Sigma Aldrich) and finally the absorbance was measured at
510 nm in a microplate reader (BioTek® Synergy HT, Winooski, VT, USA). Using the SRB assay, the GI50
concentration (concentration that inhibits 50% of net cell growth) was determined for T. lignosa infusion
and decoction extracts in each cell line.
3.4. Preparation of Cells for Other Analyses
For the analysis of the cell cycle, apoptosis, or Western blot, the NCI-H460 cells were plated
at 1.5 ˆ105 cells/well in-well plates and incubated for 24 h. Cells were then treated with different
concentrations of the T. lignosa infusion extract: 50 µg/mL (approximately the GI50 concentration),
100 µg/mL (approximately twice the GI50), and/or 150 µg/mL (approximately three times the
GI50). Blank cells (treated with medium) and Control cells (treated with a concentration of water
corresponding to the treatment with 100 µg/mL—Control 1, or 150 µg/mL—Control 2) were also
included. After treatment, cells were trypsinized and centrifuged at 1200 rpm for 5 min. Cells were
then processed according to the procedures described below.
3.5. Analysis of Cell Cycle Profile
Cells were washed in PBS, fixed with ice-cold 70% ethanol, and stored at 4 ˝C for at least 12 h.
Next, the cells were centrifuged (5 min at 1200 rpm) and the pellets were re-suspended in a solution
of PBS containing 5 µg/mL propidium iodide and 0.1 mg/mL RNase A. Cellular DNA content was
analyzed by flow cytometry and the percentage of cells in the G0/G1, S, and G2/M phases of the cell
cycle were determined using the BD Accuri™ C6 Flow cytometer (BD Biosciences) after cell debris
and aggregates exclusion and plotting at least 20,000 events per sample [31,32]. All data was analyzed
using the FlowJo software (version 7.6.5, Tree Star, Inc., Ashland, OR, USA).
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3.6. Analysis of Apoptosis
For the analysis of apoptosis, cell pellets were washed and re-suspended in 1 mL of PBS. Following
centrifugation, cells were processed for apoptosis analysis with the Annexin V-FITC Apoptosis
Detection Kit (eBioscience) by resuspension in buffer solution, as indicated by the manufacturer.
Cells were then incubated for 10 min with Human Annexin V-FICT and further incubated for 5 min
with propidium iodide. Cells were analyzed by flow cytometry using the BD Accuri™ C6 Flow
cytometer and respective software, plotting at least 20,000 events per sample [33,34]
3.7. Analysis of Protein Expression
For the analysis of protein expression, cell pellets were washed and resuspended in PBS. Cells
were centrifuged and pellets were stored at ´20 ˝C. Cell pellets were then lysed in Winman’s buffer
containing 1% NP-40, 0.1 M Tris–HCl pH 8.0, 0.15 M NaCl, and 5 mM EDTA, complemented with
protease inhibitor cocktail (Roche). The total protein content was quantified using the DC™ Protein
Assay kit (Bio-Rad, Hercules, CA, USA) according to manufacturer’s instructions. Protein lysate (20 µg)
were loaded on 12% SDS-PAGE gel and transferred into a nitrocellulose membrane (GE Healthcare,
Cleveland, OH, USA). The following primary antibodies were used: rabbit anti-PARP-1 (1:2000,
sc-7150, Santa Cruz Biotechnology, Heidelberg, Germany), mouse anti-Caspase 3 (1:2000, 05-654,
Merck Millipore, Darmstadt, Germany), and goat anti-actin (1:2000, sc-1616, Santa Cruz Biotechnology).
The corresponding secondary antibodies were: anti-rabbit IgG-HRP, anti-mouse IgG-HRP, or anti-goat
IgG-HRP (1:2000, Santa Cruz Biotechnology). The Amersham™ ECL Western Blotting Detection
Reagents (GE Healthcare), the High Performance Chemiluminescence Film (GE Healthcare), and the
Kodak GBX developer and fixer (Sigma) were used for signal detection [35,36].
3.8. Statistical Analysis
Three replicates of each aqueous extract were used. The data was statistically analyzed using the
two-tailed paired Student’s t-test.
4. Conclusions
The obtained results show that both infusion and decoction extracts from the plant T. lignosa
caused reduction in the growth of three human tumor cell lines. To our knowledge, this is the first
report of such an activity for this plant. The most potent effect was observed with the infusion extract
in the NCI-H460 cells. The effect of this extract on these cells was due to alterations in the cell cycle
profile and to induction of cellular apoptosis. Therefore, the data here presented highlights the interest
of this plant as a possible source of natural bioactive compounds with tumor cell growth inhibitory
potential. It would be interesting to isolate the compounds present in the infusion extract of this plant
and to identify which one(s) are responsible for the observed effects in this tumor cell line. It would
also be of interest to extend this study to other extracts of this plant and other cell lines.
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